# Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED)

> **NCT00705263** · — · COMPLETED · sponsor: **Schering-Plough** · enrollment: 113 (actual)

## Conditions studied

- Hepatitis C, Chronic
- Hepacivirus

## Interventions

- **BIOLOGICAL:** Peginterferon alfa-2b (SCH 54031)
- **DRUG:** Ribavirin (SCH 18908)

## Key facts

- **NCT ID:** NCT00705263
- **Lead sponsor:** Schering-Plough
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2009-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00705263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00705263, "Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00705263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*